Navigation Links
Michael DeMane Joins Thomas, McNerney & Partners as Senior Advisor
Date:4/3/2009

Former Medtronic Chief Operating Officer joins Minneapolis office.

MINNEAPOLIS, April 3 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, today announced that Michael DeMane has joined as Senior Advisor in the firm's Minneapolis office. From 2000 to 2008, Mr. DeMane held various senior positions at Medtronic Inc.'s (NYSE: MDT) U.S. and global operations, most recently as its Chief Operating Officer.

"Michael is a proven leader in the medical device industry with an unbroken record of global operating success," said Pete McNerney, Partner. "His extensive knowledge and industry contacts will be a valuable addition to our investment team, both in working with our existing portfolio and in reviewing potential new investments."

Mr. DeMane has more than 25 years of global medical device experience. Prior to his role as Chief Operating Officer at Medtronic, he served as Senior Vice President and President, Europe, Canada, Latin America and Emerging Markets. Previously he was Senior Vice President and President, Spinal, ENT and Navigation, Medtronic's fastest growing business sector, where he was responsible for growing the acquired businesses of Sofamor Danek, Xomed and Surgical Navigation Technologies. Prior to joining Medtronic, Mr. DeMane was President, Interbody Technologies, a division of Sofamor Danek and he held various senior positions at Smith & Nephew, Inc. including Managing Director for operations in Australia and New Zealand and President of the Orthopedic Implant Division. "Thomas, McNerney & Partners has extensive investment experience and wide contacts in the medical technology industry," said Mr. DeMane. "I look forward to assisting them with their portfolio companies and investment process."

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations. The firm is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. The firm has offices in Minneapolis, Stamford and San Francisco. For further information, please visit www.tm-partners.com.


'/>"/>
SOURCE Thomas, McNerney & Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
2. HealthWorldWeb Adds Michael Millenson and J.D. Kleinke to Board of Advisors
3. Fish health claims may cause more environmental harm than good: UBC-St. Michaels researchers
4. Michael J. Fox Foundation Joins Effort to Recruit 10,000 People With Parkinsons Disease to New Web-Based PD Research Community
5. Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina
6. NewCardio Elects Michael E. Hanson to Board of Directors
7. Michael Forte Joins CONNEXION Healthcare as Chief Operations Officer
8. My1Stop.com President Michael Del Chiaro Interviewed by Entrepreneur.com for ecommerce Expertise
9. ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinsons Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinsons Brain
10. Michael L. Parks, MD, Elected to the American Academy of Orthopaedic Surgeons Board of Directors
11. American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its line ... in Warner, New Hampshire at the MadgeTech headquarters. With products sold in more than ... by government agencies, including NASA. , In 2012, NASA strategically set up 17 ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James ... Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the ... founder of Retina Group of New York , is a Board Certified ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... In an effort to provide hair restoration ... to both Snapchat users and those who do not use the app. Dr. Mohebi, the ... new page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 Amarantus BioScience ... on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today ... be presenting at two upcoming investor conferences: SeeThru ... Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
Breaking Medicine Technology: